Deutsche Bank
TAK icon

Deutsche Bank’s Takeda Pharmaceutical TAK Stock Holding History

Deutsche Bank’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,705
Closed -$28.1K – 3924
2023
Q1 		$28.1K Hold
1,705
– – ﹤0.01% 3668
2022
Q4 		$26.6K Sell
1,705
-654
-28% -$9.13K ﹤0.01% 3723
2022
Q3 		$31K Hold
2,359
– – ﹤0.01% 3702
2022
Q2 		$33K Hold
2,359
– – ﹤0.01% 3855
2022
Q1 		$34K Hold
2,359
– – ﹤0.01% 3945
2021
Q4 		$32K Hold
2,359
– – ﹤0.01% 4068
2021
Q3 		$39K Hold
2,359
– – ﹤0.01% 4155
2021
Q2 		$40K Sell
2,359
-226
-9% -$3.85K ﹤0.01% 4346
2021
Q1 		$47K Sell
2,585
-366
-12% -$6.58K ﹤0.01% 4252
2020
Q4 		$54K Sell
2,951
-1,789
-38% -$31.4K ﹤0.01% 4101
2020
Q3 		$85K Buy
4,740
+366
+8% +$6.66K ﹤0.01% 3628
2020
Q2 		$78K Sell
4,374
-2,905
-40% -$52.2K ﹤0.01% 3577
2020
Q1 		$110K Sell
7,279
-270,530
-97% -$4.9M ﹤0.01% 3205
2019
Q4 		$5.48M Buy
277,809
+250,556
+919% +$4.79M ﹤0.01% 1395
2019
Q3 		$466K Sell
27,253
-34,997
-56% -$605K ﹤0.01% 2710
2019
Q2 		$1.1M Sell
62,250
-179,684
-74% -$3.27M ﹤0.01% 2785
2019
Q1 		$4.92M Buy
+241,934
New +$4.87M ﹤0.01% 1881

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's TAK Position: Q2 2023 in Review

Deutsche Bank sold out of Takeda Pharmaceutical (TAK) in Q2 2023, closing a stake of 1,705 shares — an estimated $28.1K sold.

Deutsche Bank first reported a position in TAK in Q1 2019 and held it in 17 quarters. The position peaked at $5.48M in Q4 2019. 310 funds tracked by Wall St. Rank hold TAK as of Q2 2023.

  • Deutsche Bank reported no remaining Takeda Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Deutsche Bank sold 1,705 Takeda Pharmaceutical shares in Q2 2023, an estimated $28.1K.
  • Deutsche Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 17 quarters.
  • Deutsche Bank's Takeda Pharmaceutical position peaked at $5.48M in Q4 2019.
  • 310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.